Related Experiment Video
Updated: Jul 17, 2026
08:50
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Adrenal sparing surgery for renal cell carcinoma
Chinese Medical Journal
|February 24, 2001
Summary
Adrenal sparing surgery is feasible for select renal cell carcinoma (RCC) patients. Preserving the adrenal gland during nephrectomy is safe for small tumors with normal-appearing glands, showing no significant survival difference.
Area of Science:
- Urology
- Oncology
- Surgical Pathology
Background:
- Routine adrenalectomy during radical nephrectomy for renal cell carcinoma (RCC) is increasingly questioned.
- Assessing the necessity of adrenal gland removal in RCC treatment is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the feasibility and safety of adrenal sparing surgery in patients with renal cell carcinoma (RCC).
- To determine if preserving the ipsilateral adrenal gland during nephrectomy impacts survival rates in RCC patients.
Main Methods:
- A 16-year retrospective study of 178 patients undergoing perifascial nephrectomy.
- Comparing outcomes between 96 patients with adrenal gland preservation and 82 with adrenalectomy.
- Pathological examination of 75 adrenal specimens and assessment of disease-specific survival rates.
Main Results:
- 53 out of 75 examined adrenal glands showed no pathological changes.
- Only 5 of 22 suspected adrenal metastases were histopathologically confirmed.
- No statistically significant survival difference was observed between patients who underwent adrenalectomy and those with adrenal gland preservation.
- Adrenal recurrence occurred in 2 patients with initially normal-appearing glands, both having large renal tumors.
Conclusions:
- Adrenal sparing surgery is a viable option for selected RCC patients with small tumors and macroscopically normal adrenal glands.
- Careful patient selection is essential, as adrenal metastasis can occur even with normal-appearing glands.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...